Activation of the opioid receptor by agonists such as morphine is the primary biochemical mechanism by which opioids induced analgesia in humans. Prolonged stimulation of the opioid receptor by agonist can result in desensitization at the cellular and physiological level, resulting in the loss of analgesic efficacy. Receptor internalization and downregulation may be involved in the induction of tolerance. If these processes could be inhibited, it is possible that the development of tolerance to opioid agonists could be reduced or eliminated. This would be very beneficial to patients who experience chronic pain and require the pain relieving properties of analgesics in perpetuity. These same factors which influence the development of tolerance are also involved in reinforcing aspects that lead to addiction. Therefore, any agent which reduces internalization and downregulation of the opioid receptor will reduce the onset of pharmacological tolerance and also the addictive biochemical correlates associated with long-term treatment. This research proposal focuses on m- and d-opioid receptor phosphorylation under steady-state conditions and following agonist administration. Using mass spectrometry, we will determine the precise residues which are phosphorylated on the mu- and delta-opioid receptor in basal and various agonist-stimulated experimental paradigms. Human embryonic kidney cells expressing 6x-Histidine- and FLAG epitope-tagged mouse mu- or delta-opioid receptors will be used for these experiments. The 6xHistidine- and FLAG-epitopes will allow for immobilized metal ion affinity chromatography and immunoaffinity chromatography (IMAC). Purified proteins will be isolated via SDS/PAGE and extracted for mass spectrometric analysis. The use of mass spectrometry should allow for analytical determination of phosphorylated residues.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
1F31DA015285-01
Application #
6491220
Study Section
Special Emphasis Panel (ZDA1-KXA-N (04))
Program Officer
Babecki, Beth
Project Start
2002-02-15
Project End
Budget Start
2002-02-15
Budget End
2003-02-14
Support Year
1
Fiscal Year
2002
Total Cost
$22,338
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Biochemistry
Type
Schools of Medicine
DUNS #
605799469
City
Newark
State
NJ
Country
United States
Zip Code
07107
Christoffers, Keith H; Li, Hong; Howells, Richard D (2005) Purification and mass spectrometric analysis of the delta opioid receptor. Brain Res Mol Brain Res 136:54-64
Christoffers, Keith H; Li, Hong; Keenan, Susan M et al. (2003) Purification and mass spectrometric analysis of the mu opioid receptor. Brain Res Mol Brain Res 118:119-31